SREBP1 is a critical regulator of lipid metabolism, in which it promotes expressions of lipogenic genes such as FASN and ACC, and it plays an important role in nonalcoholic fatty liver disease [32–34]. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.